The pharmacodynamic effects of rocuronium during general anesthesia in patients with type 2 diabetes mellitus

Minerva Anestesiologica

Volumn 76, Issue 2, 2010, Pages 115-119

  Alper, I ^a   Ulukaya, S ^a   Makay, O ^a   Balcioglu, T ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Anesthesia, general; Diabetes mellitus; Metabolic diseases; Neuromuscular nondepolarizing agents

Indexed keywords

ACARBOSE; FENTANYL; GLICLAZIDE; GLIMEPIRIDE; ISOFLURANE; METFORMIN; NATEGLINIDE; NEOSTIGMINE; NITROUS OXIDE; REPAGLINIDE; ROCURONIUM; ROSIGLITAZONE; THIOPENTAL;

ADULT; ARTICLE; CHOLECYSTECTOMY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; GENERAL ANESTHESIA; HUMAN; MALE; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR FUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY;

ADULT; AGED; ANDROSTANOLS; ANESTHESIA, GENERAL; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PROSPECTIVE STUDIES;

EID: 77249102635     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. McAnulty GR, Robertshaw HJ, Hall GM. Anaesthetic management of patients with diabetes mellitus. Br J Anaesth 2000;85:80-90.
2. Abu-Shakra SR, Comblath DR, Avila OL, Chaudhry V, Freimer M, Glass JD et al. Conduction block in diabetic neuropathy. Muscle Nerve 1991;14:858-62.
3. Muphy GS. Residual neuromuscular blockade: incidence, assessment, and relevance in the postoperative period. Minerva Anesthesiol 2006;72:97-109.
4. Saitoh Y, Kaneda K, Hattori H, Nakajima H, Murakawa M. Monitoring of neuromuscular block after administration of vecuronium in patients with diabetes mellitus. Br J Anaesth 2003;90:480-6.
5. Van Mook WN, Hulsewe-Evers RP. Critical illness polyneuropathy. Curr Opin Crit Care 2002;8:302-10.
6. Geller TJ, Kaiboriboon K, Fenton GA, Hayat GR. Vecuronium-associated axonal motor neuropathy: a variant of critical illness polyneuropathy? Neuromuscul Disord 2001;11:579-82.
7. Saitoh Y, Hattori H, Sanbe N, Nakajima H, Akatu M, Murakawa M. Delayed recovery of vecuronium neuromuscular block in diabetic patients during sevoflurane anesthesia. Can J Anaesth 2005;52:467-73.
8. Khuenl-Brady KS, Sparr H. Clinical pharmacokinetics of rocuronium bromide. Clin Pharmacokinet 1996;31:174-83.
9. Robertson EN, Driessen JJ, Booij LHDJ. Pharmacokinetics and pharmacodynamics of rocuronium in patients with and without renal failure. Eur J Anaesth 2005;22:4-10.
10. Cooper RA, Maddineni VR, Mirakhur RK, Wierda JMHK, Brady M, Fitzpatrick KTJ. Time course of neuromuscular effects and pharmacokinetics of rocuronium bromide during isoflurane anaesthesia in patients with and without renal failure. Br J Anaesth 1993;71:222-226.
11. Khalil M, D'Honneur G, Duvaldestin P, Slavov V, De Hys C, Gomeni R. Pharmacokinetics and pharmacodynamics of rocuronium in patients with cirrhosis. Anesthesiology 1994;80:1241-7.
12. Lowry DW, Mirakhur RK, McCarthy GJ, Carroll MT, McCourt KC. Neuromuscular effects of rocuronium during sevoflurane, isoflurane and intravenous anesthesia. Anesth Analg 1998;87:936-40.
13. nd edition. Oxford: Blackwell Scientific Publications; 1994. p. 1077-90.
14. Robertshaw HJ, Hall GM. Diabetes mellitus: anaesthetic management. Anaesthesia 2006;61:1187-90.
15. Scherpereel PA, Tavernier B. Perioperative care of diabetic patients. Eur J Anaesth 2001;18:277-94.
16. Hebl JR, Kopp SL, Schroeder DR, Horlocker TT. Neurologic complications after neuraxial anesthesia or analgesia in patients with preexisting peripheral sensorimotor neuropathy or diabetic polyneuropathy. Anesth Analg 2006; 103:1294-9.
17. Lamontagne A, Buchthal F. Electophysiological studies in diabetic neuropathy. J Neurosurg Psychiatry 1970;33:442-52.
18. Lawrence DG, Locke S. Motor nerve conduction velocity in diabetes. Arch Neurol 1961;5:483-9.